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Transient intermittent hypoxia 
exposure Disrupts neonatal 
Bone strength
Gyuyoup Kim1†, Omar Elnabawi1 , Daehwan Shin2 and Eung-Kwon Pae1*†
1 Department of Orthodontics and Pediatric Dentistry, School of Dentistry, University of Maryland, Baltimore, MD, USA, 
2 BISCO, Inc., Schaumburg, IL, USA
A brief intermittent hypoxia (IH, ambient O2 levels alternating between room air and 12% 
O2) for 1  h immediately after birth resulted in pancreatic islet dysfunction associated 
with zinc deficiency as previously reported. We hypothesized that IH exposure modu-
lates zinc homeostasis in bone as well, which leads to increased bone fragility. To test 
this hypothesis, we used neonatal rats and human osteoblasts (HObs). To examine IH 
influences on osteoblasts devoid of neural influences, we quantified amounts of alkaline 
phosphatase and mineralization in IH-treated HObs. Bones harvested from IH-treated 
animals showed significantly reduced hardness and elasticity. The IH group also showed 
discretely decreased levels of alkaline phosphatase and mineralization amounts. The 
IH group showed a decreased expression of ZIP8 or Zrt and Irt-like protein 8 (a zinc 
uptake transporter), Runx2 (or Runt-related transcription factor 2, a master protein 
in bone formation), Collagen-1 (a major protein comprising the extracellular matrix of 
the bone), osteocalcin, and zinc content. When zinc was eliminated from the media 
containing HObs using a zinc chelate and added later with zinc sulfate, Runx2, ZIP8, 
and osteocalcin expression decreased first, and recovered with zinc supplementation. 
Adenovirus-mediated ZIP8 over-expression in osteoblasts increased mineralization 
significantly as well. We conclude that IH impairs zinc homeostasis in bones and osteo-
blasts, and that such disturbances decrease bone strength, which can be recovered by 
zinc supplementation.
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inTrODUcTiOn
Chronic, repetitive, short-term exposure to hypoxia is associated with fragile bones in adults (1). 
However, reports of subnormal bone quality resulting from hypoxia in neonates or infants are rare. 
Short-term exposure to hypoxic events is common in prematurely born neonatal humans, princi-
pally in the form of apnea of infancy (2, 3). Apnea of prematurity, in particular, is a breathing pattern 
that results in intermittent hypoxia (IH) exposure, the repetitive presentation of short-term hypoxia 
followed by restoration of oxygen. IH exposure injures cardiovascular sympathetic ganglia (4), as 
well as the dorsal motor nucleus of the vagus (5, 6), and potentially elicits significant glucose and lipid 
dysregulation in later life (7, 8). Recently, our lab demonstrated diabetogenic effects resulting from 
brief IH exposure to rat neonates, including reduced zinc levels in pancreatic beta cells, contributing 
to lower insulin and high blood glucose levels (9, 10). Thus, we suspected that this short-term IH 
FigUre 1 | a typical load–displacement curve generated by 
DUh-201s. Dynamic hardness and elastic modulus were calculated using 
the equations presented. Dynamic hardness of a bone (or DH, see Eq. 1) 
was determined using test force (P) and indentation depth (D) during the 
indentation process. Reported dynamic hardness values were calculated at 
the end of indentation before retrieving the indenter. Elastic modulus of the 
sample (or E, see Eq. 2) was determined using the relationship of reduced 
modulus (Er), elastic modulus of the indenter (Ei), and elastic modulus of the 
bone sample (E). Reduced modulus was obtained using the projected area of 
contact (AP) and elastic contact stiffness (S), which was measured from the 
slope of the initial portion of the unloading curve.
March 2016 | Volume 4 | Article 152
Kim et al. Zinc Homeostasis in Neonatal Bone
Frontiers in Pediatrics | www.frontiersin.org
challenge could increase bone fragility potentially mediated by 
impaired zinc homeostasis. During IH exposure, oxidative stress, 
induced by re-oxygenation, may increase reactive oxygen species 
in the IH affected bone cells, which may favor osteoporosis as a 
consequence of oxidative stress that off-balances bone remodeling 
processes between osteoblastic and osteoclastic activities (11, 12).
Only sparse mechanistic clinical evidence is available on 
cause–effect relationships between IH challenges and reduced 
bone strength in human neonates. Type-2 diabetes is commonly 
comorbid with obstructive sleep apnea, a disease accompanied 
by IH, lending suspicion that shared processes operate in both 
the metabolic and breathing disorders (13–15). Conceivable 
causal mechanisms for increased bone fragility as sequelae of IH 
include glucose dysregulation (10, 16), increased sympathetic 
nervous system activity (17, 18), and proinflammatory condi-
tions (19, 20) in addition to disrupted homeostasis of zinc, an 
essential trace metal in cell metabolism. We hypothesize that 
IH exposure in neonates may result in fragile bones via zinc 
deficiency in later life, irrespective of glucose metabolic dysfunc-
tion. Using a neonatal rat model developed in our lab and human 
osteoblast (HOb) cells, we evaluated whether a 1-h IH exposure 
during the neonatal period increases bone fragility and whether 
this fragility is associated with reduced zinc levels resulted from 
IH exposure.
MaTerials anD MeThODs
Preparation of animals
Near end-term pregnant Sprague-Dawley rats were purchased 
and maintained until parturition. Within 3  h after birth, 12 
offspring (5 males and 7 females), together with the mother of 
this experimental group, were randomly placed in a customized 
IH chamber that alternated oxygen concentration between room 
air (20.5% O2) and a hypoxic condition (12% O2) every 240  s 
for 1 h, with food and water accessible ad libitum, as described 
previously (9, 21). Ten control pups (five males and five females) 
and their mother were maintained in room air. After the initial 
1-h IH treatment, pups were kept in room air until euthanasia. 
To examine long-term IH effects on glucose regulation, we main-
tained IH-treated and untreated control pups for 12 weeks and 
measured their blood glucose and insulin levels. All procedures 
carried out and related to the procedure and animal care were 
approved by the Institutional Animal Care and Use Committee of 
the University of Maryland, Baltimore (Permit number D121101).
Bone Physical strength studies
To estimate physical strength of bone, we used micro-hardness 
[dynamic hardness (DH)] and elastic modulus of the tibia and 
mandible. The bones were isolated from all 3-week-old rats and 
were measured using an ultra-micro hardness tester (DUH-W201S, 
Shimadzu, Japan). Each bone specimen was embedded in poly-
(methyl methacrylate) (PMMA) mold, and the sample surface was 
ground and polished using grit paper. Maximum indentation force 
of 100 mN was applied onto the bone surface using a Berkovich 
indenter throughout the experiments. DH was calculated by meas-
uring an indentation depth at the end of the indentation process 
before unloading and maximum indentation force. DH, indicated 
in millinewton per square micrometer, is a load-bearing material 
property of indentation contact, based on both plastic and elastic 
deformations of a specimen under test. As the indenter was driven 
into the surface of test samples, both elastic and plastic deforma-
tions occur. Since the DH measure is obtained during indentation 
loading, DH represents hardness of material based on both elastic 
and plastic deformations of bone. Calculated elastic modulus of 
a sample is based on elastic contact theory. Elastic modulus (E), 
indicated in gigapascal, was calculated from the initial portion of 
the elastic unloading curve, based on the method proposed by 
Oliver and Pharr (22) (Figure 1). This relationship was driven by 
the assumption that elastic displacements are produced by both 
the indenter and the specimen.
culturing human Osteoblasts
Human osteoblasts (Cell Applications, Inc.) were maintained 
in normal osteoblast growth medium (OGM), with added fetal 
bovine serum, ascorbic acid, and gentamicin/amphotericin-B 
(Lonza Walkersville, Inc.), under standard conditions in a 37°C 
and 5% CO2 incubator. Differentiation and mineralization of 
osteoblasts were induced by supplementing OGM with 10 mM 
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β-glycerophosphate and 200 nM hydrocortisone-21-hemisucci-
nate for 14 days. The medium was replaced every 2–3 days until 
cells were harvested.
Intermittent hypoxia treatment was performed and followed 
by cell differentiation. The purchased osteoblast cells were placed 
in a hypoxia chamber (Billups-Rothenberg, Inc.), and internal 
gases alternated between room air and a hypoxic gas mixture (1% 
O2, 5% CO2, and 94% N2) every 10 min, 10 times to mimic IH 
conditioning in tissue levels. After IH exposure, the osteoblasts 
were differentiated for 2 weeks. We could not maintain the cells 
for 3  weeks to match with our in  vivo experiments due to cell 
senescence.
Zinc depletion/addition experiments were carried out 
concomitantly. At confluence, osteoblasts were treated with dif-
ferentiation medium containing 5 μM TPEN [N,N,N′,N′-tetrakis-
(2-pyridylmethyl)-ethylenediamine], which is a cell-permeable 
zinc-specific chelate, and followed by ZnSO4 treatment at 0, 10, 
and 50 μM concentrations for 14 days.
histological staining
Additional 3-day-old male pups exposed to IH (n = 2) and room 
air (n = 2) conditions were euthanized using CO2 and fixed in 
10% neutral buffered formalin (Sigma-Aldrich Co.) for 7 days. 
Hind limbs were isolated and outsourced to the Pathology and 
Laboratory Medicine Services at UCLA for immunohistochem-
istry staining. The specimens were decalcified for paraffin embed-
ding. Comparable sections of paraffin embedded specimens were 
processed with anti-Runx2 antibody (Sigma-Aldrich Co.) on 
the slides in accordance with the manufacturer’s guidelines. All 
sections were visualized using diaminobenzidine reaction and 
counterstained with hematoxylin. The corresponding sections 
were stained with Masson Trichrome (Sigma-Aldrich Co.), 
in accordance with the manufacturer’s protocol. Histological 
evaluations were performed with Aperio ImageScope (Leica 
Microsystems, Inc.) on digital images.
Western Blotting
Proteins were extracted from the harvested hind limbs of 3-week-
old rats. Isolated femurs and tibias were snap-frozen by adding 
liquid nitrogen on a mortar and homogenized using a pestle. 
Pulverized samples were incubated in the red blood cell lysis 
buffer (155 mM NH4Cl, 140 mM NaHCO3, and 0.1 mM EDTA, 
pH 7.3) for 10 min, and supernatants were removed by centrifuge. 
Pellets were lysed in ice-cold RIPA buffer containing protease 
inhibitor cocktails (Roche Applied Science). A controlled amount 
of proteins was separated using SDS-PAGE and transferred onto 
a PVDF membrane using an electroblot. After blocking with 
5% milk TBS-T, the blots were probed using primary antibodies 
(anti-ZIP8 antibody, Pierce Biotechnology, Inc.; anti-Runx2 anti-
body, Sigma-Aldrich Co.; anti-β-actin antibody, Cell Signaling 
Technology, Inc.; and anti-Collagen-1 antibody, Santa Cruz 
Biotech.) and followed by a horseradish peroxidase-conjugated 
secondary antibody. Chemiluminescent reagents were used to 
detect immunoreactive proteins, and the membrane was exposed 
to X-ray films.
Zinc assay
Intracellular zinc levels were estimated using Zinc Colorimetric 
Assay Kit (BioVision, Inc.) as previously described (9). Thirty 
micrograms of whole-cell lysate was precipitated by TCA, and 
the supernatant was mixed with the zinc reagent in the 96-well 
plate according to the manufacturer’s protocol. Absorbance was 
measured using Epoch spectrophotometer (BioTek Instruments, 
Inc.) at 560 nm.
alkaline Phosphatase activity and 
Mineralization assays
To estimate alkaline phosphatase activity, the harvested cells were 
washed with PBS and fixed for 1  min in 10% neutral buffered 
formalin. After fixation, the cells were washed with PBS and 
stained with BCIP–NBT substrate solution (Sigma-Aldrich Co.) 
for 10 min at room temperature, according to the manufacturer’s 
protocol. After staining, mono-layered cells were washed with 
PBST containing 0.05% Tween 20 and covered with PBS for 
visualization.
Alizarin Red S staining was performed to assess mineralization. 
The cells were fixed for 40 min in 10% neutral buffered formalin 
and washed with distilled water. The fixed cells were incubated 
with sufficient Alizarin Red S staining solution (Alfa Aesar) at 
room temperature in the dark for 45 min. After the solution was 
removed, the cell monolayer was washed with distilled water four 
times and PBS was added to visualize calcium deposits.
elisa assay for Osteocalcin
Assays for intracellular osteocalcin quantification were 
performed with cell lysates using an ELISA kit (Takara Bio, 
Inc.), according to the manufacturer’s protocol. Shortly, 
samples were incubated on the monoclonal anti-osteocalcin 
coated plate for 2  h, followed by incubation with the per-
oxidase labeled antibody for 1  h. The peroxidase substrate 
3,3′,5,5′-tetramethylbenzidine and stop solution were added 
for the reaction, developing a color. The amounts of osteocal-
cin were quantified via absorbance reading at 450 nm using a 
spectrophotometer.
adenoviral Vector of ZiP8
Adenovirus-GFP (as a control) and -ZIP8 (HA-tagged) were 
purchased from Applied Biological Materials, Inc. (Canada). At 
confluence, osteoblasts were infected with adenovirus for 36 h at 
a multiplicity of infection of 100, and followed by supplementing 
differentiation medium. Evaluation of adenoviral-ZIP8 infection 
was performed by Western blots using HA-probe (Santa Cruz 
Biotechnology, Inc.).
statistical analysis
Statistical significance for group differences was tested by a 
two-tailed t-test. Each assay at cellular or subcellular level was 
repeated at least three times. Data were summarized in the form 
of mean ± SD for bone strength and elasticity measurements to 
exhibit a clear relationship between variances and sample size. 
Mean ± SEM was used for other measurements.
FigUre 2 | comparisons of dynamic hardness, and elasticity, of a long bone (tibia) and the mandible between male and female control and ih 
animals. C (closed) represents the control group (five males and five females), and IH (open) represents the intermittent hypoxia group (five males and seven 
females). (a) Note that hardness in males (control tibia 76.9 ± 20.20 vs. IH tibia 30.5 ± 14.78 and control mandible 42.6 ± 11.41 vs. IH mandible 16.5 ± 5.39) and 
in females (control tibia 68.9 ± 8.84 vs. IH tibia 37.4 ± 14.18 and control mandible 49.0 ± 5.11 vs. IH mandible 26.6 ± 6.57). (B) Note that elasticity of male control 
tibia 4.53 ± 2.19 vs. IH 1.25 ± 0.42 and control mandible values of 1.67 ± 0.73 vs. IH mandible 0.44 ± 0.18. Control female tibia values were 7.02 ± 1.05 vs.  
IH tibia 2.28 ± 1.06, and female control mandible values were 2.01 ± 1.92 vs. IH mandible of 0.40 ± 0.14.
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resUlTs
Outcomes of the analyses on the bones and HObs were compared 
between control and IH groups. Differences in gender were tested 
for bone physical strength only. Leg and mandibular bones har-
vested from the IH-treated rats and IH-treated HObs obtained 
in vitro showed parallel outcomes.
Bone hardness and elasticity
Measurements, including DH and elastic modulus, were obtained 
from each load–displacement curve, and means and SDs were 
calculated (Figure 1). Both hardness and elasticity significantly 
differed between control and IH-treated tibias and mandibles in 
accordance with t-tests. DH in IH-treated animals was approxi-
mately 60% of control values in males. However, in females, the 
IH treatment effect was less pronounced, approximating 45% 
(Figure  2A). Differences between IH and control groups in 
elasticity were greater than those of DH for both males (approxi-
mately 70%) and females (approximately 67–80%) (Figure 2B). 
A notable further disparity (10% or more decline in elasticity 
compared to the declined value for hardness) appeared after IH 
treatment in both long bones and mandibles. The results suggest 
that a short-term neonatal exposure to IH damages bone integrity 
in rodents with sex-dependent manner on hardness and elasticity.
histological and subcellular changes of 
the Bones after ih exposure
Immunohistochemical staining using Runx2 antibody showed 
decreased expression of Runx2 protein (brown color) in 
the diaphysis of the femur (Insets a and d), harvested from 
IH-treated animals (Figure  3A). The differences in diameter 
and length of the bones between groups appeared insignificant. 
The quantity of osteoblasts expressing Runx2 protein in the 
medullary area did not show a notable disparity. In the insets b 
and e of Figure 3A, epiphyseal plate (growth plate) areas were 
also magnified and highlighted. Masson trichrome staining 
further clarified the zones of proliferation and hypertrophy of 
growth plate areas (Figure  3B); yet no significant difference 
was noted in the growth plate areas as well. Western blot results 
indicated decreased expression of Runx2, Collagen-1, and ZIP8 
transporter proteins (Figure  3C). Zinc content in whole-cell 
extracts of the tibia declined significantly after IH treatment 
(Figure 3D).
FigUre 3 | comparisons of bone integrity between controls and ih rats. (a) First column: overview from which a–f panels are derived. Immunohistochemical 
staining using Runx2 antibody shows decreased expression of Runx2 protein (brown color) in the femur, harvested from IH-treated animals (panel d), over control 
(panel a). Panels b and e contrast the differences in the length of growth plate in the tibia (white scale bar = 500 μm). Panels c and f show cell density of the 
proliferating and hypertrophic zone of the growth plate (black scale bar = 100 μm). (B) Masson trichrome staining visualizes the zones of proliferation and 
hypertrophy of growth plate areas. No significant difference in cell counts appears between control and IH-treated bones. Gray scale bars = 300 μm. (c) Western 
blot assays demonstrate a decreased cellular expression of Runx2, Collagen-1 (COL1), and ZIP8 transporter proteins with respect to β-actin. (D) Zinc content in the 
tibia (whole bone extracts, n = 3) declined significantly after IH treatment.
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changes in subcellular compositions of 
human Osteoblasts
After IH challenge, HObs showed decreased expression of alka-
line phosphatase (Figure  4A) and mineralization (Figure  4B). 
Western blots noted decreased Runx2, Collagen-1, and ZIP8 pro-
tein contents (Figure 4C) as shown such in rat bone. Osteoclacin 
measurements shown in Figure  4D resulted in a significant 
decline after IH treatment. The amount of zinc estimated in 
whole-cell lysates obtained from three sets of osteoblasts culture 
(n =  3), significantly declined after IH treatment (Figure  4E). 
These results suggest that unbalanced zinc homeostasis may be 
a mechanism underlies a cause–effect relationship between IH 
insults and bone fragility.
Zinc effects on Bone Formation
To investigate effects of zinc on the osteoblast differentiation 
after IH, the amount of alkaline phosphatase (Figure  5A) and 
the degree of mineralization (Figure  5B) were measured after 
application of TPEN (zinc chelate) or/and zinc supplement. 
Differentiation was declined by zinc chelate as shown on the 
second columns of Figures 5A,B. Yet, when zinc was added, the 
expression of alkaline phosphatase and the amount of miner-
alization significantly increased zinc concentration dependently. 
Western blot assays showed that the addition of zinc increases 
the level of Runx2, ZIP8, and Collagen-1 protein expression 
(Figure 5C). Osteocalcin levels measured in the control cells did 
not change along with the changes of zinc levels; yet the level 
of osteocalcin decreased significantly after IH treatment, then 
recovered by zinc addition (Figure 5D). When exogenous ZIP8 
transporters were overexpressed using adenovirus (Figure 5E), 
expression of alkaline phosphatase and mineralization assessed 
by Alizarin S Red increased (Figure 5F). To recap, IH-damaged 
bone integrity could be reversed by zinc supplement.
ih effects on glucose regulation
Longer term IH effects were investigated for future direction 
on seven male pups. As shown in Table 1, the level of blood 
insulin were significantly low (176.3 vs. 15.3) at p = 0.001. The 
results suggest that IH effects on insulin excretion deteriorated 
further as animals age. Interestingly, however, blood glucose 
levels were maintained at a control level. No difference in 
weight was noted.
FigUre 4 | comparisons between control and ih-treated osteoblasts. 
IH-treated human osteoblasts show decreased expression of alkaline 
phosphatase (a) and mineralization (B), assessed by Alizarin S Red. Runx2, 
Collagen-1, and ZIP8 protein contents (c) assayed using Western blots. 
Osteocalcin levels (D) quantified from cell lysates using ELISA assays show a 
significant decline with IH. Zinc contents (e) estimated in whole-cell lysates 
obtained from three sets of osteoblasts culture dishes (n = 3), decreased 
after IH treatment.
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DiscUssiOn
The substantial declines in bone hardness and elasticity after brief 
neonatal IH exposure were unexpected. However, we already 
demonstrated that IH exposure elicits diabetes-like symptoms 
via a disturbed zinc homeostasis in pancreatic islets in rats (9); 
we investigated here whether a similar mechanism triggers a 
cause–effect loop between IH and an increased fragility of bones. 
Because apnea of prematurity is a common ventilation pattern in 
preterm neonatal babies, severe IH exposure could result in unex-
pected public health issue. Particularly, 12-week data set shown 
in Table 1 demands an extensive investigation on 12-week-old or 
older animals.
The intergroup differences in elasticity between IH-treated and 
control animals were greater than those of hardness, particularly 
in female pups. This finding may suggest a faulty composition 
of the extracellular matrix, which may be represented by the 
decreased Collagen-1 protein shown in Figure 3C. The in vitro 
studies showed a similar tendency. The extracellular matrix of 
bones is composed of collagen fibers, together with other fibers 
made of proteoglycan or elastin. Thus, the decreased collagen 
content and cross-link formation (23) in the extracellular matrix 
may be a critical factor that contributes to the significantly dimin-
ished bone elasticity in the tibia and mandible after IH exposure. 
The decreased osteocalcin levels after IH as shown in Figure 4D 
may underscore this explanation, because osteocalcin is a bone 
matrix protein that regulates hydroxyapatite size and shape 
through its vitamin-K-dependent, γ-carboxylated form (24, 25). 
More investigation of other proteins, in addition to Collagen-1 
and osteocalcin, will clarify this issue.
We did not factor bone turnover processes in interpretation of 
these data; instead, we focused on bone formation, because bone 
formation is impaired in Type-1 diabetic patients (26). In our 
findings, a significant decrease in Runx2 protein in the IH group 
may well be expected, because Runx2 is a master transcription 
factor for osteogenesis, engaged in various up- and downstream 
functions of many proteins secreted by osteoblasts, which boost 
differentiation of osteoblasts (27). Regardless of the underly-
ing condition, as Runx2 expression decreases, bone formation 
decreases (28). Yet, as discussed earlier by us and others, we do 
not know whether oxidative stress inflicted a decrease of Runx2 
expression (29) or the decreased osteocalcin level influence 
Runx2 expression via a feedback process (30, 31).
Zinc is a trace metal involved in numerous essential body 
biochemical functions, including nucleic acid metabolism 
(32), and functions as a part of zinc finger proteins (33) and 
metalloenzymes for antioxidant function (34). Therefore, 
long-term zinc deprivation may result in serious dysfunction 
and structural damage in some organs, such as bone (35). 
Much evidence supports the finding that extracellular matrix 
mineralization is disturbed via Runx2 modulation by zinc 
(36–38). Zinc is also involved in calcium phosphate function 
(39) and leptin production (40), which helps modulate bone 
formation (25, 41). Thus, insufficient mineralization of bone 
spicule and matrix may be resulted from unbalanced activi-
ties of Runx2 and osteocalcin due to a sub-optimum level of 
cytosol zinc.
Zinc uptake transporters may play an important role in bone 
structure as well; zinc, metallothionein, and the interactions 
between the two are critical to bone formation (42). Zinc absorbed 
through diet should be imported into the cytoplasm of osteoblasts 
via zinc uptake transporters, such as ZIP8, which will boost osteo-
calcin production as well as bone formation after IH exposure. 
Despite ZIP8 transporter has been suggested to be a critical player 
in the pathogenesis of osteoarthritis (43), its functions in bone 
modeling and remodeling are largely unknown, because most 
research thus far has focused on zinc exporters (ZnT) (44).
A question arises whether zinc supplementation can reverse 
osteogenesis retardation in patients with osteoporosis (45), 
providing an inexpensive intervention for a costly condition. 
Our current findings support that possibility. Although the 
mechanisms associated with cytosolic zinc levels that can facili-
tate osteogenic, or suppress osteoclastic activities are unknown 
(46), research on various pathways is emerging (47, 48).
We did not solely aim to distinguish whether IH-induced 
neonatal diabetes results in decreased bone integrity or whether 
the increased bone fragility may result from a loss of zinc 
TaBle 1 | insulin and glucose levels in blood of 12-week-old male rats 
had ih-treated immediate after birth.
sample size insulin (pM/l) glucose 
(mM/l)
ratio 
(insulin/
glucose)
Weight (g)
IH pups (n = 4) 15.3 ± 12.61* 9.1 ± 1.19 1.8 ± 1.50 494 ± 57
Control pups 
(n = 3)
176.3 ± 41.19* 9.3 ± 1.59 19.3 ± 5.77 490 ± 39
*p = 0.001.
FigUre 5 | Bone formation process rescued by zinc supplementation. Alkaline phosphatase contents (a) and the degree of mineralization (B), estimated by 
Alizarin S Red declined after IH treatment (control vs. IH in each column). After the zinc chelate TPEN was added, no signs of alkaline phosphatase (a) and 
mineralization (B) appeared [second column in (a) and (B)]. Supplementation by zinc sulfate recovers the expression of alkaline phosphatase and mineralization 
(+10 and +50 for IH). (c) Addition of zinc also increases the level of Runx2, ZIP8, and Collagen-1 protein expression (+10 and +50 for both control and IH). 
However, osteocalcin levels did not vary with zinc levels in the media (D) in control; yet, osteocalcin expression decreased under the IH condition significantly and 
recovered with zinc supplementation (see +10 and +50 for IH). (e) indicates that increased concentration of ZIP8 protein is of an exogenous origin, i.e., from 
adenovirus. (F) shows that ZIP8 transporter over-expression increased alkaline phosphatase production (top row in blue color) and bone mineralization (bottom row 
in pink color).
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homeostasis. Further, it is not yet conclusive whether the find-
ings here are secondary to neural disturbances, e.g., brain or 
ganglia structural damage resulting in sympathetic disturbances 
triggered by IH insults, or secondary to leptin dysfunction 
alone (49). Therefore, whether zinc deficiency is the primary 
mechanism for the reduced hardness and elasticity of bones 
deems to require further challenges. However, we speculate that 
zinc supplementation could help patients exposed to IH by such 
mechanisms as apnea of prematurity at an early age. It is unclear 
if zinc supplementation would reverse the progress of tissue 
damage or ongoing pathological changes in human bones; such a 
determination would require a controlled clinical trial partition-
ing both IH exposure and zinc levels.
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